G2B awarded with Biotech New Frontiers 2022

Biotech New Frontiers Award 2022Gate2Brain

Gate2Brain award with Biotech New Frontiers 2022

Gate2Brain attended the 5th Congress of Medical Biotechnology / 2nd Congress of Iberian Medical Biotechnology held last week at the Escola Superior de Saúde do Politécnico do Porto, where our CEO, Meritxell Teixió, gave a plenary lecture.

The main goal of this meeting was to create a scientific framework in the field of Medicinal Biotechnology and related fields, to promote the exchange of ideas and experiences, collaboration and mobility among researchers, particularly from Portugal and Spain and contribute to a better and broader international agenda for Medicinal Biotechnology.

Gate2Brain’s unexpected joy reached its peak when we found out that we had been granted the Biotech New Frontiers Award 2022.

This award is for all those who have contributed to making Gate2Brain a reality, thus bringing medicines beyond barriers. Thank you very much.

/by
You might also like
Grit International Female Accelerator!Grit International Female AcceleratorG2B joined the Grit International Female Accelerator
Three University of Barcelona spin-offs led by women will receive funding as part of the Women TechEU pilot callFundació Bosch i GimperaThree University of Barcelona spin-offs will receive funding from Women TechEU pilot call
talento científicotalento cientificoFounding a company in times of pandemic
It’s Gate2Brain second anniversary!! 🎂 The creativity, work and dedication of Gate2Brain's team can only be matched with its desire to bring medicines beyond barriers.Gate2BrainGate2Brain second anniversary
Gate2Brain participated on June 29 at The Milner Therapeutics Institute (MTI) Pitch Day 🗣️at the University of Cambridge, the cradle of cancer research. The MTI Pitch Day is a great initiative designed to highlight companies like us to investors, to create connections between academic entrepreneurship and investment to promote therapeutic companies. A great event that pulls together on one side academic, preclinical and research and on the other industry in an effort to push forward collaborative drug development and increase the standard of patient careGate2Brain at MIT Pitch Day at University of Cambridge
VII SEQT Summer School “Medicinal Chemistry and Chemical Biology in Drug DiscoveryGate2BrainGate2Brain at the VII SEQT Summer School
PaidhosGate2Brain wants to deliver drugs to the brain to combat intact barrier brain tumors, such as DIPG
G2B receives funding to accelerate its transfer to the market and society
Gate2Brain

Gate2Brain is a biotech company focused on the development of therapeutics that efficiently cross biological barriers such as the blood-brain barrier. We use a radically innovative peptide-based patented technology.

Where to find us

Barcelona Scientific Park
Baldiri Reixac, 4-8, Torre I
08028 Barcelona, Spain
info@gate2brain.com

Social

Gate2Brain attends the 1st edition of the University of Barcelona spin-offs...Gate2Brain attends the 1st edition of the, Fundació Bosch i Gimpera, University of Barcelona spin-offs gathering “Cockroaches vs Unicorns”universitat de barcelonaGate2Brain's retreat 2022Gate2BrainGate2Brain’s retreat 2022